000 | 01783 a2200529 4500 | ||
---|---|---|---|
005 | 20250517025359.0 | ||
264 | 0 | _c20150623 | |
008 | 201506s 0 0 eng d | ||
022 | _a1878-3686 | ||
024 | 7 |
_a10.1016/j.ccell.2015.03.004 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aZhu, Eric F | |
245 | 0 | 0 |
_aSynergistic innate and adaptive immune response to combination immunotherapy with anti-tumor antigen antibodies and extended serum half-life IL-2. _h[electronic resource] |
260 |
_bCancer cell _cApr 2015 |
||
300 |
_a489-501 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, N.I.H., Intramural; Research Support, U.S. Gov't, Non-P.H.S. | ||
650 | 0 | 4 | _aAdaptive Immunity |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aCD8-Positive T-Lymphocytes _xdrug effects |
650 | 0 | 4 | _aDrug Synergism |
650 | 0 | 4 | _aHalf-Life |
650 | 0 | 4 | _aImmunity, Innate |
650 | 0 | 4 | _aImmunotherapy |
650 | 0 | 4 |
_aInterleukin-2 _xmetabolism |
650 | 0 | 4 |
_aKiller Cells, Natural _xdrug effects |
650 | 0 | 4 | _aMice |
650 | 0 | 4 | _aMice, Inbred C57BL |
650 | 0 | 4 |
_aNeoplasms _ximmunology |
700 | 1 | _aGai, Shuning A | |
700 | 1 | _aOpel, Cary F | |
700 | 1 | _aKwan, Byron H | |
700 | 1 | _aSurana, Rishi | |
700 | 1 | _aMihm, Martin C | |
700 | 1 | _aKauke, Monique J | |
700 | 1 | _aMoynihan, Kelly D | |
700 | 1 | _aAngelini, Alessandro | |
700 | 1 | _aWilliams, Robert T | |
700 | 1 | _aStephan, Matthias T | |
700 | 1 | _aKim, Jacob S | |
700 | 1 | _aYaffe, Michael B | |
700 | 1 | _aIrvine, Darrell J | |
700 | 1 | _aWeiner, Louis M | |
700 | 1 | _aDranoff, Glenn | |
700 | 1 | _aWittrup, K Dane | |
773 | 0 |
_tCancer cell _gvol. 27 _gno. 4 _gp. 489-501 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.ccell.2015.03.004 _zAvailable from publisher's website |
999 |
_c24803949 _d24803949 |